【用戶】蓋瑞李
【年級】大二下
【評論內容】Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants.[1][2] It is a monoclonal antibody targeted at the CD3 receptor,[3] a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.[2]是一種靶向CD3受體的單株抗體，是第一種被批准用於人類臨床單株抗體。FROM: wikipedi...
【用戶】Bryan
【年級】國三上
【評論內容】44.下列何者為免疫抑制劑Muromonab-CD3主要之副作用？ (A)細胞激素釋放性症狀(Cytokine release syndrome) (B)嗜中性白血球過低症(bone marrow suppression).....看完整詳解